| 英文名称 |
中文名称 |
CAS号 |
操作 |
| 2-Chlorobenzoic acid |
2-氯苯甲酸 |
118-91-2 |
详细
|
| 3,5-DINITRO-4-HYDROXYBENZOIC ACID |
布美他尼2-b |
41430-25-5 |
详细
|
| 3-nitro-4-phenoxybenzoic acid |
布美他尼2-a |
202209-14-1 |
详细
|
| Bumetanide Impurity 4 |
布美他尼杂质4 |
56106-56-0 |
详细
|
| Hydrochlorothiazide EP Impurity C |
氢氯噻嗪杂质C |
402824-96-8 |
详细
|
| 4-Amino-6-chlorobenzene-1,3-disulfonamide |
氢氯噻嗪杂质A |
121-30-2 |
详细
|
| 1,3-Dinitroglycerin |
硝化甘油溶液EP杂质E |
623-87-0 |
详细
|
| 3-nitro-4-phenoxy-5-sulfobenzoic acid |
布美他尼5-a |
751422-00-1 |
详细
|
| 1,2-Dinitroglycerin |
硝化甘油溶液EP杂质D |
621-65-8 |
详细
|
| Levocarnitine Impurity A |
左卡尼汀杂质A顺式异构体 |
835638-57-8 |
详细
|
| 3-amino-4-hydroxy-5-nitrobenzoic acid |
布美他尼5-d |
267014-44-8 |
详细
|
| 3,5-diamino-4-phenoxybenzoic acid |
布美他尼3-a |
688318-18-5 |
详细
|
| N-(4-AMinobenzenesulfonyl) SulfaMethoxazole |
磺胺甲噁唑杂质B |
135529-16-7 |
详细
|
| Rosuvastatin calcium |
瑞舒伐他汀钙 |
147098-20-2 |
详细
|
| Methyl 3-(3,4-dihydroxyphenyl)propanoate |
3,4-二羟基苯丙酸甲酯 |
3598-22-9 |
详细
|
| Fructosazine |
果糖嗪 |
13185-73-4 |
详细
|
| (1R,2S,3S)-Aprepitant |
阿瑞匹坦RSS杂质 |
172822-28-5 |
详细
|
| N,N-diethyl-2,2-difluoroacetamide |
N，N- 二乙基-2,2-二氟乙酰胺 |
686-11-3 |
详细
|
| Aprepitant Impurity 8 HCl |
阿瑞匹坦RSS杂质盐酸盐 |
1333998-27-8 |
详细
|
| Olmesartan Medoxomil EP Impurity D |
奥美沙坦酯杂质D |
1020157-01-0 |
详细
|
| Bromocriptine mesylate |
甲磺酸溴隐亭 |
22260-51-1 |
详细
|
| Landiolol Impurity 18 |
兰地洛尔杂质18 |
1582797-17-8 |
详细
|
| 2-(R)-[1-(S)-(3,5-Bis(trifluoroMethyl)phenyl)ethoxy]-3-(S)-fluorophenylMorpholine |
阿瑞匹坦SRS杂质盐酸盐 |
170729-79-0 |
详细
|
| Trazodone Impurity J |
盐酸曲唑酮杂质J |
1263278-79-0 |
详细
|
| (1R,2S,3R)-Aprepitant |
阿瑞匹坦RSR杂质 |
1185502-97-9 |
详细
|
| Trimethoprim EP Impurity A |
甲氧苄啶杂质A |
213745-86-9 |
详细
|
| SulfaMethoxazole Related CoMpound F |
磺胺甲噁唑杂质F |
17103-52-5 |
详细
|
| Doxapram EP Impurity A |
多沙普仑EP杂质A |
3192-64-1 |
详细
|
| Levosimendan Impurity 10 |
左西孟旦杂质C |
134678-47-0 |
详细
|
| (S)-(((1-(6-aMino-9H-purin-9-yl)propan-2-yloxy)Methyl)phosphoryl)bis(oxy)bis(Methylene) isopropyl dicarbonate fuMarate |
富马酸替诺福韦二吡呋酯异构体 |
1432630-26-6 |
详细
|
| Candesartan Cilexetil EP IMpurity G |
坎地沙坦酯杂质G |
139481-59-7 |
详细
|
| Propafenone EP Impurity F |
盐酸普罗帕酮片杂质F |
1329643-40-4 |
详细
|
| 2-sulfo Tryptophan |
2-磺基色氨酸 |
|
详细
|
| 3-acetamidophthalic acid |
3-乙酰胺基邻苯二甲酸 |
15371-06-9 |
详细
|
| 1,2-Benzenediol, 4-[2-[(1-methylethyl)amino]ethyl]-, hydrochloride (1:1) |
盐酸异丙肾上腺素杂质A |
5178-52-9 |
详细
|
| NA |
O-乙酰化鲑降钙素 |
|
详细
|
| Candesartan Cilexetil EP Impurity F |
坎地沙坦酯杂质F |
914613-36-8 |
详细
|
| Lenalidomide Impurity 1 |
来那度胺杂质01 |
2197420-75-8 |
详细
|
| N,N,N',N'-tetrabutylpropane-1,3-diamine |
N、N，N'，N'-四丁基丙烷-1,3-二胺 |
94107-99-0 |
详细
|
| 3-Pyridinamine, 6-(2-methyl-2H-tetrazol-5-yl)- |
杂质22 6-(2-甲基-2H-四唑-5-基)吡啶-3-胺 |
1552277-18-5 |
详细
|
| Candesartan Cilexetil EP Impurity E |
坎地沙坦酯杂质E |
914613-35-7 |
详细
|
| Candesartan Cilexetil EP Impurity D |
坎地沙坦酯杂质D |
1185256-03-4 |
详细
|
| Propafenone EP Impurity D |
盐酸普罗帕酮片杂质D |
91401-73-9 |
详细
|
| 2-AMINO-6-METHOXYCARBONYL BENZOIC ACID |
3-氨基邻苯二甲酸-1-甲酯 |
103259-06-9 |
详细
|
| CEFTAZIDIME IMPURITY A |
头孢他啶杂质A |
1000980-60-8 |
详细
|
| 1-Butanamine, N,N-dibutyl-4-chloro- |
N-(3-氯丁基)二丁基胺 |
1250316-60-9 |
详细
|
| NA |
鲑降钙素杂质A |
|
详细
|
| AMpicillin EP IMpurity C |
氨苄西林EP杂质C |
49841-96-5 |
详细
|
| Rivaroxaban iMpurity |
利伐沙班杂质C |
1616563-62-2 |
详细
|
| Lenalidomide Impurity 3 |
来那度胺杂质 3 |
295357-66-3 |
详细
|
| 2-ThiophenecarboxaMide, 5-chloro-N-[(2R)-2-hydroxy-3-[[4-(3-oxo-4-Morpholinyl)phenyl]aMino]propyl]- |
利伐沙班杂质L |
721401-53-2 |
详细
|
| Ceftazidime EP Impurity B |
注射用头孢他啶杂质B |
97148-38-4 |
详细
|
| CIS-4,7,10,13,16,19-DOCOSAHEXAENOIC ACID METHYL ESTER |
二十二碳六烯酸甲酯 |
301-01-9 |
详细
|
| Trazodone Impurity E |
盐酸曲唑酮杂质E |
1346599-35-6 |
详细
|
| 3-(2-Methylpropyl)pentanediamide |
3-(2-甲基丙基)戊烷二酰胺 |
1262340-21-5 |
详细
|
| Torezolid |
杂质24 5-氯-2-(2-甲基-2H-四唑-5-基)吡啶 |
2095840-88-1 |
详细
|
| FLUCOFURON |
N,N'-二[4-氯-3-(三氟甲基)苯基]脲 |
370-50-3 |
详细
|
| 3-(Acetylamino)-1,2-benzenedicarboxylic Acid Methyl Ester |
杂质Z |
144841-10-1 |
详细
|
| Phosphonic acid, P-[[[2-amino-9-[(2R)-2-(phosphonomethoxy)propyl]-9H-purin-6-yl]amino]methyl]- |
6-磷酸甲基加合物PMPA |
1425688-72-7 |
详细
|
| Urea, N-(2-chloro-4-hydroxyphenyl)-N'-methyl- |
乐伐替尼杂质62 |
1556190-62-5 |
详细
|
| NA |
鲑降钙素注射液降解杂质2 |
|
详细
|
| CDP-082-SM2-imp H |
Malonic acid hydrogen 1-isopropyl ester |
56766-77-9 |
详细
|
| Glycine, N-[(4-hydroxy-7-phenoxy-3-isoquinolinyl)carbonyl]-, methyl ester |
罗沙司他Z3 |
2599284-48-5 |
详细
|
| Folic acid IMpurity E |
叶酸杂质E |
|
详细
|
| Valsartan Isopropyl Ester |
缬沙坦异丙酯SK-SM3-Q1 |
1245820-09-0 |
详细
|
| Cefditoren iMpurity 10, ring open diMer |
头孢托仑匹酯7-反式异构体 |
878002-86-9 |
详细
|
| methyl 1-chloro-4-hydroxy-7-phenoxyisoquinoline-3-carboxylate |
罗沙司他Z1 |
1421312-33-5 |
详细
|
| N4,N7-bis(3-chloro-4-fluorophenyl)-6-nitro-4,7-Quinazolinediamine |
3-氯-4-氟苯胺 在喹唑啉环 4，7 位双取代 |
2044702-52-3 |
详细
|
| Glycine, N-[(4-hydroxy-1-methyl-6-phenoxy-3-isoquinolinyl)carbonyl]- |
罗沙司他P-11 |
808118-34-5 |
详细
|
| TiMolol IMpurity E |
噻吗洛尔EP杂质E |
1026075-53-5 |
详细
|
| Mirabegron Impurity 10 |
米拉贝隆杂质10 |
|
详细
|
| 4-(Acetylamino)phthalic anhydride |
4-乙酰氨基邻苯二甲酸酐 |
22235-04-7 |
详细
|
| Daunorubicin EP Impurity E |
柔红霉素EP杂质E |
|
详细
|
| 2-[(5-Methyl-2-thiazolyl)amino]-2-oxoacetic Acid |
美洛昔康杂质 |
82514-69-0 |
详细
|
| (R,S)-Palonosetron Hydrochloride |
帕洛诺司琼杂质D |
135755-51-0 |
详细
|
| AztreonaM IMpurity F |
氨曲南杂质F |
102579-57-7 |
详细
|
| (2S)-2-(2-Oxopyrrolidin-1-yl)butanoic acid |
左乙拉西坦RC1 |
102849-49-0 |
详细
|
| ETHYL-(3,4-DIMETHOXY-PHENYL)-AMINE |
|
32953-13-2 |
详细
|
| 4-Quinazolinamine, N-(3-chloro-2-fluorophenyl)-7-fluoro-6-nitro- |
3-氯-4-氟苯胺取代基位置异构体 |
936558-43-9 |
详细
|
| 3-(2-Naphtyloxy)-1,2-propanediol |
普萘洛尔杂质10 |
34646-56-5 |
详细
|
| Isavuconazonium sulfate |
艾沙康唑硫酸盐对照品 |
946075-13-4 |
详细
|
| 4(3H)-Quinazolinone, 6-nitro-7-[[(3S)-tetrahydro-3-furanyl]oxy]- |
杂质10 |
1621182-18-0 |
详细
|
| LXI-15028-02 |
4-羟基-N,N,2-三甲基-1-(苯甲基)-1H-苯并咪唑-6-甲酰胺 |
1640981-20-9 |
详细
|
| 3-Isoquinolinecarboxylic acid, 4-hydroxy-7-phenoxy- |
罗沙司他SMA-1( |
2376195-48-9 |
详细
|
| 1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one, 5-chloro- |
盐酸曲唑酮杂质4 |
1781591-94-3 |
详细
|
| zolpidem impurity A |
唑吡坦杂质A |
|
详细
|
| Loxoprofen Impurity D |
洛索洛芬钠杂质D |
1091621-61-2 |
详细
|
| 1-((2-hydroxyethyl)amino)-3-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ol |
奥硝唑杂质1 |
1415561-33-9 |
详细
|
| NA |
罗沙司他Z2 |
421312-35-7 |
详细
|
| 1H-Benzimidazole-5-carboxamide, 7-[[(4R)-5,7-difluoro-3,4-dihydro-2H-1-benzopyran-4-yl]oxy]-N,N,2-trimethyl- |
LXI-15028对映异构体 |
942195-56-4 |
详细
|
| 2-((2-naphthyloxy)methyl)-oxiran |
普萘洛尔杂质11 |
5234-06-0 |
详细
|
| 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,6-naphthyridine-3-carboxamide |
外消旋酰胺基萘啶 |
2084136-51-4 |
详细
|
| 4-(4-cyano-2-methoxyphenyl)-5-methoxy-2,8-dimethyl-1,4-dihydro- 1,6-naphthyridine-3-carboxamide |
外消旋-甲基-酰胺基-TH-萘啶 |
2640280-84-6 |
详细
|
| 2-Propanol, 1-(ethylamino)-3-(1-naphthalenyloxy)- |
普萘洛尔杂质25 |
2111-24-2 |
详细
|
| Finerenone Impurity 22 |
外消旋-异丙基-酰胺基-TH-萘啶 |
2640280-85-7 |
详细
|
| 2-Sulfobenzoic acid |
美洛昔康杂质 |
632-25-7 |
详细
|
| Tofacitinib Impurity 6 |
枸橼酸托法替布杂质HC1309-326 |
1640972-35-5 |
详细
|
| Loxoprofen Impurity E |
洛索洛芬钠杂质E |
1091621-62-3 |
详细
|
| Triamcinolone Impurity 1 |
哈西奈德杂质16 |
2367-73-9 |
详细
|
| 9-Fluoro-16a,17-(isopropylidenedioxy)corticosterone |
哈西奈德杂质14 |
1524-86-3 |
详细
|